Suppr超能文献

权衡疫苗接种的风险与益处。

Weighing the risks and benefits of vaccination.

作者信息

Glickman L T

机构信息

Department of Veterinary Pathobiology, Purdue University, West Lafayette, Indiana 47907, USA.

出版信息

Adv Vet Med. 1999;41:701-13. doi: 10.1016/s0065-3519(99)80054-8.

Abstract

The following summarizes this author's current thoughts regarding veterinary vaccines and their safety: 1. Every licensed animal vaccine is probably effective, but also produces some adverse effects. 2. Prelicensing studies of vaccines are not specifically designed to detect adverse vaccine reactions. 3. An improved system of national postmarketing surveillance is required to identify most adverse vaccine reactions that occur at low and moderate frequency. 4. Even a good postmarketing surveillance system is unlikely, however, to detect delayed adverse vaccine reactions, and the longer the delay the less likely they will be associated with vaccination. 5. Analytic epidemiologic (field) studies are the best way to link vaccination with delayed adverse reactions, but these are often hindered by incomplete vaccination histories in medical records in veterinary practice and by a lack of veterinarians in industry trained in epidemiologic methods. 6. Each licensed veterinary vaccine should be subjected to a quantitative risk assessment, and these should be updated on a regular basis as new information becomes available. 7. Risk assessment should be used to identify gaps in information regarding the safety and efficacy of vaccines, and appropriate epidemiologic studies conducted to fill these gaps that contribute to the uncertainty in risk estimates. 8. Risk assessment is an analytical process that is firmly based on scientific considerations, but it also requires judgments to be made when the available information is incomplete. These judgments inevitably draw on both scientific and policy considerations. 9. Representatives from industry, government, veterinary medicine, and the animal-owning public should be involved in risk management, that is, deciding between policy options. The controversy regarding vaccine risks is intensifying to the point that some animal owners have stopped vaccinating their animals. They offer as justification the belief that current vaccines are "just too dangerous." Some owners report that since they completely stopped vaccinating their animals, they have been healthy. What they fail to realize is that a high percentage of animal owners are responsible and do vaccinate their animals, thus providing "herd immunity" protection to the unvaccinated animals whom they contact. The solution to the vaccine controversy is not to abandon vaccination as an effective means of disease prevention and control, but rather to encourage vaccine research to answer important questions regarding safety and to identify the biological basis for adverse reactions. Key questions to be answered include these: What components of vaccines are responsible for adverse reactions? What is the genetic basis for susceptibility to adverse health effects in animals? How can susceptible individuals be identified? Do multivalent vaccines cause a higher rate of adverse reactions than monovalent vaccines? Is administration of multiple doses of monovalent vaccines really any safer than administering a single multivalent vaccine? These and other vaccine-related questions deserve our attention as veterinarians so we can fulfill our veterinary oath to relieve animal suffering and "above all else, do no harm."

摘要

以下总结了该作者目前对兽用疫苗及其安全性的看法

  1. 每一种获得许可的兽用疫苗可能都是有效的,但也会产生一些不良反应。2. 疫苗的许可前研究并非专门设计用于检测疫苗不良反应。3. 需要一个改进的国家上市后监测系统,以识别大多数低频率和中等频率发生的疫苗不良反应。4. 然而,即使是一个良好的上市后监测系统也不太可能检测到延迟性疫苗不良反应,而且延迟时间越长,它们与疫苗接种相关的可能性就越小。5. 分析性流行病学(现场)研究是将疫苗接种与延迟性不良反应联系起来的最佳方法,但这些研究常常受到兽医实践中病历中疫苗接种史不完整以及行业内缺乏接受过流行病学方法培训的兽医的阻碍。6. 每一种获得许可的兽用疫苗都应进行定量风险评估,并且应随着新信息的获得定期更新这些评估。7. 风险评估应用于识别疫苗安全性和有效性方面信息的差距,并进行适当的流行病学研究以填补这些导致风险估计存在不确定性的差距。8. 风险评估是一个基于科学考量的分析过程,但当现有信息不完整时也需要做出判断。这些判断不可避免地会借鉴科学和政策两方面的考量。9. 行业、政府、兽医学和动物饲养公众的代表应参与风险管理,即在政策选项之间做出决定。关于疫苗风险的争议正在加剧,以至于一些动物主人已停止给他们的动物接种疫苗。他们给出的理由是认为当前的疫苗“太危险了”。一些主人报告说自从他们完全停止给动物接种疫苗后,动物一直很健康。他们没有意识到的是,很大比例的动物主人是负责的,会给他们的动物接种疫苗,从而为他们接触到的未接种疫苗的动物提供“群体免疫”保护。解决疫苗争议的办法不是放弃接种疫苗这一有效的疾病预防和控制手段,而是鼓励疫苗研究以回答有关安全性的重要问题,并确定不良反应的生物学基础。需要回答的关键问题包括:疫苗的哪些成分会导致不良反应?动物对健康不良影响易感性的遗传基础是什么?如何识别易感个体?多价疫苗比单价疫苗引起更高的不良反应发生率吗?多次接种单价疫苗真的比接种一次多价疫苗更安全吗?作为兽医,这些以及其他与疫苗相关的问题值得我们关注,这样我们才能履行兽医誓言,减轻动物痛苦,“首要的是,不造成伤害”。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验